VivoSeq
Other

Hypovolemia

1

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Hypovolemia is an early-stage landscape with 1 program across 1 company. The most active players are Milestone Pharmaceuticals Inc..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

Milestone Pharmaceuticals Inc.

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Oxygen Gas

The Hospital for Sick Children

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Recruiting1 · 25%
Terminated1 · 25%

Clinical Trials

Trial Activity

Acetated Ringer´s Solution in Experimental Hypovolemia
Recruiting·OOslo University Hospital·Phase 4·NCT05705115·12 enrolled
Supplemental Oxygen in Hypovolemia
Completed·OOslo University Hospital·Phase 1·NCT05150418·15 enrolled
Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients
Terminated·—·Phase 4·NCT01531803·3 enrolled
Effectiveness of the Pressure Recording Analytical Method in Predicting the Fluid Responsiveness in Pediatric Surgical Critical Care Patients
Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT04186416·19 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)